| HOME >> MEDICINE >> TECHNOLOGY |
- Key M&A activities and licensing agreements that took place from 2005–2011 in the contraceptives market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
- Devise a more tailored country strategy through understanding of key drivers and barriers in the contraceptives market.
- Develop key strategic initiatives by understanding the key focus areas of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Contraceptives Market to 2017- Introduction 9
2.1 GBI Research Report Guidance 10
3 Contraceptives Market to 2017 - Market Overview 11
3.1 Introduction 11
3.2 Revenue Forecasts for Contraceptives Market 11
3.2.1 Revenues 11
3.2.2 Annual Cost of Usage for Contraceptives 14
3.2.3 Share of Prescription and OTC Contraceptives 15
3.3 Drivers and Barriers for Contraceptives Market 16
3.3.1 Drivers for Contraceptives 16
3.3.2 Barriers for Contraceptives 16
4 Contraceptives Market to 2017- Geographical Landscape 17
4.1 The US 17
4.1.1 Revenue 17
4.1.2 Annual Cost of Therapy for Contraceptives 18
4.2 Top Five Countries of Europe 19
4.2.1 Revenue 19
4.2.2 Annual Cost of Therapy for Contraceptives 20
4.3 Japan 21
4.3.1 Revenue 21
4.3.2 Annual Cost of Therapy for Contraceptives 22
5 Contraceptives Market to 2017 - Therapeutic landscape 23
5.1 Oral Contraceptives 23
5.1.1 Intro
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |